v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Sales Agreement [Member]
Common Stock [Member]
Common Stock [Member]
At The Market Sales Agreement [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
At The Market Sales Agreement [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022 $ 107,459   $ 60   $ 317,590   $ (122) $ (210,069)
Beginning Balance (in shares) at Dec. 31, 2022     59,943,430          
Stock-based compensation 2,247       2,247      
Issuance of common stock from exercise of stock options 74       74      
Issuance of common stock from exercise of stock options (in shares)     146,081          
Issuance of common stock from Employee Stock Purchase Plan 68       68      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     50,091          
Issuance of common stock, net of commissions and allocated fees, less issuance costs   $ 1,671   $ 1   $ 1,670    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)       750,000        
Issuance of common stock from pre-funded warrant exercise     $ 7   (7)      
Issuance of common stock from pre-funded warrant exercise (in shares)     7,394,097          
Unrealized gains on available-for-sale marketable securities 93           93  
Net loss (29,065)             (29,065)
Ending Balance at Dec. 31, 2023 82,547   $ 68   321,642   (29) (239,134)
Ending Balance (in shares) at Dec. 31, 2023     68,283,699          
Stock-based compensation 3,588       3,588      
Issuance of common stock from exercise of stock options $ 394       394      
Issuance of common stock from exercise of stock options (in shares) 262,009   262,009          
Issuance of common stock from Employee Stock Purchase Plan $ 70       70      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     45,483          
Issuance of common stock, net of commissions and allocated fees, less issuance costs 46,767 $ 14,099 $ 13 $ 5 46,754 $ 14,094    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)     12,500,000 4,498,065        
Issuance of common stock from pre-funded warrant exercise     $ 8   (8)      
Issuance of common stock from pre-funded warrant exercise (in shares)     8,013,375          
Unrealized gains on available-for-sale marketable securities 90           90  
Net loss (47,911)             (47,911)
Ending Balance at Dec. 31, 2024 $ 99,644   $ 94   $ 386,534   $ 61 $ (287,045)
Ending Balance (in shares) at Dec. 31, 2024     93,602,631